News & Events
< Back to News Overview
CogState Signs Agreement with ALZA Corporation
25 / 08 / 2005
CogState Ltd (ASX:CGS) announces today that they have signed an agreement with ALZA Corporation, a member of the Johnson and Johnson group of companies, to provide cognitive testing services for a phase I clinical study.
The total revenue under the agreement will be recognized by the end of the calendar year.
Dr. Peter Bick, CEO for CogState comments "This first contract with ALZA Corporation provides extra diversity to CogState's customer base and further demonstrates the growing demand for CogState's cognitive testing services in the pharmaceutical clinical trials area."
For more information, please contact Dr Peter Bick on 03 9664 1300.
The total revenue under the agreement will be recognized by the end of the calendar year.
Dr. Peter Bick, CEO for CogState comments "This first contract with ALZA Corporation provides extra diversity to CogState's customer base and further demonstrates the growing demand for CogState's cognitive testing services in the pharmaceutical clinical trials area."
For more information, please contact Dr Peter Bick on 03 9664 1300.